Does MK-801 discrimination constitute an animal model of schizophrenia useful for detecting atypical antipsychotics? (Q52174060)

26 April 2018

title

Does MK-801 discrimination constitute an animal model of schizophrenia useful for detecting atypical antipsychotics? (English)

1 reference

26 April 2018

1 reference

J A Smith

1

1 reference

26 April 2018

C Boyer-Millar

series ordinal

2

1 reference

26 April 2018

A J Goudie

series ordinal

3

1 reference

26 April 2018

language of work or name

English

0 references

publication date

1 October 1999

1 reference

26 April 2018

Pharmacology, Biochemistry and Behavior

published in

1 reference

26 April 2018

volume

64

1 reference

26 April 2018

issue

2

1 reference

26 April 2018

page(s)

429-433

1 reference

26 April 2018

Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900077-5

7 January 2021

Phencyclidine. Physiological actions, interactions with excitatory amino acids and endogenous ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900077-5

7 January 2021

Clozapine but not haloperidol antagonizes an MK-801 discriminative stimulus cue.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900077-5

7 January 2021

Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900077-5

7 January 2021

Antipsychotic drugs block phencyclidine receptor-mediated neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900077-5

7 January 2021

Perceptual masking of the chlordiazepoxide discriminative cue by both caffeine and buspirone.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900077-5

7 January 2021

Comparative characterisation of the discriminative stimulus properties of clozapine and other antipsychotics in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900077-5

7 January 2021

Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900077-5

7 January 2021

Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900077-5

7 January 2021

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900077-5

7 January 2021

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900077-5

7 January 2021

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900077-5

7 January 2021

Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900077-5

7 January 2021

Cholinergic mediation of the discriminative stimulus properties of clozapine.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900077-5

7 January 2021

Normal cerebrospinal fluid and brain glutamate levels in schizophrenia do not support the hypothesis of glutamatergic neuronal dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900077-5

7 January 2021

The discriminative stimulus effects of MK-801: Generalization to other N-methyl-D-aspartate receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900077-5

7 January 2021

MK-801-induced stereotypy and its antagonism by neuroleptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900077-5

7 January 2021

Abnormal excitatory neurotransmitter metabolism in schizophrenic brains

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900077-5

7 January 2021

Concurrent locomotor stimulation and decrease in dopamine release in rats and mice after treatment with the competitive NMDA receptor antagonists D-CPPene and CGS 19755

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900077-5

7 January 2021

Differential effects of CGP 37849 and MK-801, competitive and noncompetitive NMDA antagonists, with respect to the modulation of sensorimotor gating and dopamine outflow in the prefrontal cortex of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900077-5

7 January 2021

The behavioral pharmacology of NMDA receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900077-5

7 January 2021

10.1016/S0091-3057(99)00077-5

Identifiers

DOI

1 reference

26 April 2018

release_3lzrs2tcurapbm3rbqdlx4obvy

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3lzrs2tcurapbm3rbqdlx4obvy

24 November 2022

mapped directly with Wikidata item

PubMed ID

10515325

1 reference

26 April 2018